Can lifestyle choices like diet and hydration help manage some of the common side effects of GLP-1 medications
Food and Drug Administration (FDA) approved Zepbound injections for adults who are: Obese, defined on the Zepbound label as having a body mass index (BMI) of 30 or greater Overweight, defined on the Zepbound label as having a BMI of 27, and at least one potentially weight-related condition , such as high blood pressure, type 2 diabetes or high cholesterol Patients are typically prescribed Zepbound in addition to a reduced-calorie diet and increased physical activity
Burneo JG, Faught E, Knowlton R, Morawetz R, Kuzniecky R
For mild local rashes, you can often continue treatment while monitoring symptoms
The biosimilar reimbursement revolution: Navigating disruption and seizing competitive advantage
If you prioritize slots, look for volatility labels and demo modes to calibrate risk